The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes
✍ Scribed by J. Blagg; S.A. Ballard; K. Cooper; P.W. Finn; P.S. Johnson; F. MacIntyre; G.N. Maw; P.L. Spargo
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 338 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
The design, synthesis and biological properties of homochiral non-steroidal inhibitors of both isozymes of human 5¢t-reductase are described. The o-hydroxy aniline moiety of the initial lead (1) can be replaced by a 3-acyl indole isostere, whilst the minimum energy conformation of the benzyl ether in the potent inhibitor ( 3) is mimicked by the conformationally locked benzodioxolane system in the potent non-steroidal inhibitor (7). Pharmacokinetics and oral efficacy in a rat model of BPH are presented for (3) and ( 7).
📜 SIMILAR VOLUMES
A series of 4a-methyl-3,4,4a,9-tetrahycIrophenanthrene-2-carhoxyllc acids aud 2-phosphiuic acids has heen prepared and evaluated in vitro as inhibitors of human recombinant steroid Sa-reductase. 7-Chloro-4amethyl-3,4,4a,9-tetrahydrophenauthrene-2-csrhoxylic acid, 5, is a marginally sclectlve inhibit
Steroidal 3-carboxy-20-ketones have been prepared within two structural series, the androsta-3,5-dienes and the estra-1,3,5-trienes, as potential inhibitors of types 1 and 2 steroid 5 alpha-reductase, the enzyme activity responsible for the final step in biosynthesis of dihydrotestosterone. These co